← SynDRA
EPZ-015666
SynDRA canonical compound SYN0062938 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PRMT5 |
|---|
| Mechanism of action | protein arginine N-methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- protein arginine N-methyltransferase inhibitor
- PRMT5 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- 3XV
- EPZ 015666
- EPZ015666
- EPZ015666 (GSK3235025)
- GSK3235025
- GTPL8287
- epz015666
- Epz015666
- RefChem:137435
- MFCD28411588
- C20H25N5O3
- orb1301095
- SCHEMBL15825186
- SCHEMBL29349784
- SCHEMBL32667790
- EX-A559
- ZKXZLIFRWWKZRY-KRWDZBQOSA-N
- BDBM177922
- GLXC-06250
- NSC785299
- s7748
- AKOS027252262
- CCG-268441
- CS-3995
- EBC-521291
- NSC-785299
- GSK 3235025
- NCGC00386436-03
- NCGC00386436-07
- AC-35304
- AS-74874
- BE166956
- HY-12727
- T6076
- EPZ015666, >=98% (HPLC)
- P14671
- F504693
- US9675614, 166
- BRD-K70446295-001-01-7
Look up EPZ-015666 in the interactive SynDRA portal →